oral dissolvable semaglutide | Starts at $249/mo Oral Semaglutide Gets FDA Approval

Clinical evidence: The SURMOUNT-1 trial, published in the New England Journal of Medicine , showed that participants on the highest dose of tirzepatide (15 mg) lost an average of 22.5 percent of their body weight over 72 weeks the most weight loss ever demonstrated by a pharmaceutical agent in a clinical trial (Jastreboff et al., 2022)

In this section, well explore how alcohol impacts blood sugar levels, why this matters when youre on semaglutide, and some tips for managing blood sugar if you choose to drink

Some people do great on 8 mg or even less

Treatment discontinuation due to gastrointestinal side effects occurred in 5.6% of semaglutide users versus 2.7% of tirzepatide users